Otrdien, 30. apr\u012bl\u012b, akciju sabiedr\u012bbas Grindeks \u201eNasdaq Riga\u201d iesniegtie 2018. gada revid\u0113tie konsolid\u0113tie finan\u0161u p\u0101rskati liecina, ka Koncerna apgroz\u012bjums 2018. gad\u0101 bija 145,5 milj. eiro, kas ir par 13,1 milj. eiro vai par 10% vair\u0101k nek\u0101 2017. gad\u0101. Savuk\u0101rt koncerna zaud\u0113jumi, kas attiecin\u0101mi uz m\u0101tes sabiedr\u012bbas akcion\u0101riem, 2018. gad\u0101 bija 9,7 milj. eiro.<\/p>\n\n\n\n
Koncerna zaud\u0113jumi ir saist\u012bti ar vair\u0101kiem faktoriem. Saska\u0146\u0101 ar starptautisk\u0101 finan\u0161u p\u0101rskatu standarta \u201eFinan\u0161u instrumenti\u201d pras\u012bb\u0101m ir izveidots 15,3 milj. eiro uzkr\u0101jums nedro\u0161iem debitoriem, k\u0101 ar\u012b p\u0113c vispus\u012bga \u012bstenoto p\u0113tniec\u012bbas un att\u012bst\u012bbas projektu nov\u0113rt\u0113juma uz\u0146\u0113muma vad\u012bba, \u0146emot v\u0113r\u0101, ka daudzos projektos ir sasniegts iev\u0113rojams progress, nol\u0113ma koncentr\u0113t finan\u0161u resursus tiem un atteikties no projektiem, kuru rezult\u0101ts ir neskaidrs. T\u0101d\u0113j\u0101di nerealiz\u0113tie p\u0113tniec\u012bbas un izstr\u0101des projekti 2,0 milj. eiro apm\u0113r\u0101 tika attiecin\u0101ti uz izmaks\u0101m. B\u016btiski r\u0101d\u012bt\u0101ju ietekm\u0113ja ar\u012b nekustamo \u012bpa\u0161umu akt\u012bvu v\u0113rt\u012bbas samazin\u0101\u0161an\u0101s un val\u016btas kursa sv\u0101rst\u012bbas Krievij\u0101, kas rad\u012bja 3,3 milj. eiro zaud\u0113jumus.<\/p>\n\n\n\n
2018. gad\u0101 Koncerna sara\u017eot\u0101 produkcija eksport\u0113ta uz 87 pasaules valst\u012bm kopum\u0101 par 135,1 milj. eiro, kas ir par 12,6 milj. eiro vai par 10% vair\u0101k nek\u0101 2017. gad\u0101.
Grindeks gatavo z\u0101\u013cu p\u0101rdo\u0161anas apjoms 2018. gad\u0101 bija 136,6 milj. eiro un ir palielin\u0101jies, sal\u012bdzinot ar 2017. gadu, par 12,4 milj. eiro. P\u0101rdo\u0161anas apjoms Krievij\u0101, p\u0101r\u0113j\u0101s NVS valst\u012bs un Gruzij\u0101 2018. gad\u0101 sasniedza 87,0 milj. eiro, kas ir par 5,9 milj. eiro vai par 7% vair\u0101k nek\u0101 2017. gad\u0101. Sal\u012bdzinot ar 2017. gadu, 2018. gad\u0101 iev\u0113rojam\u0101kais p\u0101rdo\u0161anas apjoma pieaugums sasniegts \u2013 Kazahst\u0101n\u0101 par 28%, Kirgizst\u0101n\u0101 par 20%, Azerbaid\u017e\u0101n\u0101 un Baltkrievij\u0101 par 17% un Uzbekist\u0101n\u0101 par 16%.<\/p>\n\n\n\n
Gatavo z\u0101\u013cu p\u0101rdo\u0161anas apjoms Eiropas Savien\u012bbas valst\u012bs 2018. gad\u0101 sasniedza 45,5 milj. eiro, kas ir par 5,1 milj. eiro vai 13% vair\u0101k nek\u0101 2017. gad\u0101. P\u0101rdo\u0161anas apjoms 2018. gad\u0101, sal\u012bdzinot ar 2017. gadu, Bulg\u0101rij\u0101 ir palielin\u0101jies 9 reizes, Polij\u0101 3 reizes, Austrij\u0101 un \u010cehij\u0101 2 reizes, Sp\u0101nij\u0101 par 78%, D\u0101nij\u0101 par 60%, Zviedrij\u0101 par 27% un Horv\u0101tij\u0101 par 25%.
2018. gad\u0101 akt\u012bvo farmaceitisko vielu p\u0101rdo\u0161anas apjoms sasniedza 7,4 milj. eiro, kas ir par 0,5 milj. eiro vai 8% vair\u0101k nek\u0101 2017. gad\u0101. \u0160aj\u0101 period\u0101 liel\u0101kais Grindeks akt\u012bvo farmaceitisko vielu eksports tika veikts uz ES valst\u012bm, Jap\u0101nu, Austr\u0101liju un ASV.<\/p>\n\n\n\n
AS Grindeks valdes priek\u0161s\u0113d\u0113t\u0101js Juris Bundulis: \u201e2018. gad\u0101 koncerna p\u0101rdo\u0161anas apjomu esam k\u0101pin\u0101ju\u0161i par 10%. Tas ir stabils pieaugums un labs atsp\u0113riens turpm\u0101kaj\u0101m iecer\u0113m. V\u0113los uzsv\u0113rt, ka \u0161is farm\u0101cijas industrij\u0101 bija \u013coti svar\u012bgs gads, jo, iev\u0113rojot jaun\u0101s ES Z\u0101\u013cu viltojumu direkt\u012bvas pras\u012bbas, z\u0101\u013cu ra\u017eot\u0101jiem bija j\u0101ievie\u0161 z\u0101\u013cu verifik\u0101cijas sist\u0113ma, kas nodro\u0161ina katru z\u0101\u013cu paci\u0146u ar autentifik\u0101cijas kodu. Visos Grindeks koncerna farmaceitisk\u0101s ra\u017eo\u0161anas uz\u0146\u0113mumos jaun\u0101 sist\u0113ma sekm\u012bgi darbojas. N\u0101kotn\u0113 Grindeks darb\u012bbas rezult\u0101tus noteiks m\u016bsu sp\u0113ja papla\u0161in\u0101t produktu kl\u0101stu, k\u0101 ar\u012b prasmes izmantot jaunas iesp\u0113jas.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"
Otrdien, 30. apr\u012bl\u012b, akciju sabiedr\u012bbas Grindeks \u201eNasdaq Riga\u201d iesniegtie 2018. gada revid\u0113tie konsolid\u0113tie finan\u0161u p\u0101rskati liecina, ka Koncerna apgroz\u012bjums 2018. gad\u0101 bija 145,5 milj. eiro,…<\/p>\n","protected":false},"author":3,"featured_media":2782,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-2785","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-jaunums"],"acf":[],"_links":{"self":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/posts\/2785","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/comments?post=2785"}],"version-history":[{"count":0,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/posts\/2785\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/media\/2782"}],"wp:attachment":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/media?parent=2785"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/categories?post=2785"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/tags?post=2785"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}